[Results of the treatment for infant acute lymphoblastic leukemia treated in the program Dana-Faber Cancer Institute. Report of Polish Pediatric Study Group for Leukemia and Lymphoma].
We present courses and treatment's results in 8 infants with acute lymphoblastic leukaemia (ALL) treated according Dana-Faber Cancer Institute protocol between 1994-1998 year. Complete remission (RC) was achieved in 8 children. Relapses were diagnosed between 6 to 20 month, only one achieved II RC. Four children are alive: in I RC-2, in II RC-1, in partial remission 1 and the treatment was ended in one. Treatment's results in infants with ALL are still unsatisfactory.
Sońta-Jakimczyk
D
D
Katedry i Kliniki Hematologii Dzieciecej i Chemioterapii Slaskiej Akademii Medycznej w Katowicach.
Olejnik
I
I
Armata
J
J
Bogusławska-Jaworska
J
J
Kołecki
P
P
Kowalczyk
J
J
Rokicka-Milewska
R
R
Chybicka
A
A
Derwich
K
K
Drabko
K
K
Hicke-Roberts
A
A
Kubiczek
K
K
Steczowicz
M
M
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D011044:Poland; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000401:mortality; D012074:Remission Induction; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome
D000970:Antineoplastic Agents